Acute respiratory distress syndrome is associated with impaired alveolar macrophage efferocytosis

Eur Respir J. 2021 Sep 9;58(3):2100829. doi: 10.1183/13993003.00829-2021. Print 2021 Sep.


ARDS patients have decreased alveolar macrophage efferocytosis, which is associated with increased alveolar inflammation, and may contribute to worse clinical outcomes, including mortality. Upregulation of efferocytosis may offer a therapeutic strategy.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Macrophages, Alveolar*
  • Phagocytosis
  • Respiratory Distress Syndrome*